News | January 10, 2025
Carbogen Amcis successfully completed Swissmedic inspection of its Vionnaz facility
The site’s GMP Certification has been successfully renewed
The site’s GMP Certification has been successfully renewed
Acquisition expands high-value medical platform
This product is an oral SYK inhibitor and suppresses platelet destruction by macrophages and platelet depletion
Lilly plans to hire approximately more than 1,000 new highly-skilled team members
Consequent to this appointment, Sarosh Shetty ceases to be Interim CEO of ICH.
NutrifyGenie AI, a leading AI-driven platform, was integral in designing scientifically differentiated formulations for a multinational client
Inaugurates new facilities to further NIMHANS’ mission of delivering cutting-edge care in mental health and neurosciences
Parkinson's disease (PD) is one of the most common neurological disorders caused by the death of dopamine-secreting neurons in the brain
Immedica to commence a cash tender offer to acquire all issued and outstanding shares of Marinus for an enterprise value of approximately US$ 151 million
The company's portfolio includes 21 commercialized products, 19 approved ANDAs, 4 CGT designations, 6 filed ANDAs, and 45 products in its pipeline
Subscribe To Our Newsletter & Stay Updated
